全文获取类型
收费全文 | 1326篇 |
免费 | 90篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 88篇 |
妇产科学 | 47篇 |
基础医学 | 145篇 |
口腔科学 | 33篇 |
临床医学 | 171篇 |
内科学 | 362篇 |
皮肤病学 | 42篇 |
神经病学 | 79篇 |
特种医学 | 130篇 |
外科学 | 118篇 |
综合类 | 50篇 |
预防医学 | 69篇 |
眼科学 | 8篇 |
药学 | 58篇 |
中国医学 | 2篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 7篇 |
2022年 | 5篇 |
2021年 | 23篇 |
2020年 | 23篇 |
2019年 | 25篇 |
2018年 | 22篇 |
2017年 | 25篇 |
2016年 | 25篇 |
2015年 | 33篇 |
2014年 | 33篇 |
2013年 | 45篇 |
2012年 | 45篇 |
2011年 | 36篇 |
2010年 | 67篇 |
2009年 | 51篇 |
2008年 | 48篇 |
2007年 | 51篇 |
2006年 | 32篇 |
2005年 | 50篇 |
2004年 | 34篇 |
2003年 | 35篇 |
2002年 | 25篇 |
2001年 | 16篇 |
2000年 | 20篇 |
1999年 | 25篇 |
1998年 | 47篇 |
1997年 | 43篇 |
1996年 | 41篇 |
1995年 | 32篇 |
1994年 | 45篇 |
1993年 | 34篇 |
1992年 | 21篇 |
1991年 | 32篇 |
1990年 | 23篇 |
1989年 | 27篇 |
1988年 | 28篇 |
1987年 | 33篇 |
1986年 | 14篇 |
1985年 | 16篇 |
1984年 | 11篇 |
1983年 | 18篇 |
1982年 | 18篇 |
1981年 | 13篇 |
1980年 | 16篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 18篇 |
1976年 | 14篇 |
1975年 | 13篇 |
1974年 | 5篇 |
排序方式: 共有1431条查询结果,搜索用时 15 毫秒
61.
62.
63.
F B Waldo 《The Journal of pediatrics》1990,116(5):S78-S85
IgA nephropathy (Berger disease) is defined by the dominant or codominant deposition of IgA in the renal mesangium. There is much evidence in vitro to suggest up-regulation of the IgA immune response in patients. Data from tonsillar and bone marrow-derived lymphocytes and from in vivo immunization studies indicate that the primary defect is an up-regulated systemic one, rather than mucosal IgA production. Several lines of evidence suggest that increased IgA production alone is inadequate to explain the pathogenesis of Berger disease. Murine models of IgA nephropathy indicate that local complement activation mediated by deposited IgG is essential for mesangial cell proliferation and subsequent renal injury. Circulating immune complexes from patients with Berger disease contain IgA and IgG within the same lattice. In vitro studies of model immune aggregates containing various mixtures of IgA and IgG indicate that the IgG is the site of complement activation and fixation. The IgA in the aggregate actually inhibits both complement activation and binding to erythrocyte complement receptor CR1. This effect of IgA may prevent effective immune complex clearance. In future studies, more emphasis should be placed on the roles of IgG and complement in the pathogenesis of IgA nephropathy. 相似文献
64.
J C Chan F G Boineau E J Ruley G M Lum R A Weiss F B Waldo A Pomrantz S Hellerstein R N Fine 《The Journal of pediatrics》1990,116(2):S24-S27
The Growth Failure in Children With Renal Diseases Study, a double-blind, multicenter clinical trial with 108 children entered into the control period over 4.3 years of patient enrollment (December 1984 to April 1989), is being extended for 3 years (December 1988 to December 1991) to provide the time needed to accrue additional patients, aged between 1 1/2 and 10 years, with glomerular filtration rates of 20 to 75 ml/min/1.73 m2. The study design of randomization to two treatment arms (1,25-dihydroxyvitamin D vs dihydrotachysterol) requires a total of 108 patients with a minimum of 6 months of treatment to test the long-term effectiveness and safety of 1,25-dihydroxyvitamin D, an essential part of the therapeutic regimen for children with chronic renal insufficiency. The frequent longitudinal assessments of nutrition and growth in children with chronic renal insufficiency can better define the natural history of renal disease and its influence on growth. Similar data in the treatment period will define the impact of treatment with 1,25-dihydroxyvitamin D3 versus dihydrotachysterol on this natural history. Linear growth must be observed long enough (6 to 12 months minimum) to permit valid quantitation and comparison of the two vitamin D treatment arms, the multiple confounding variables that affect growth (e.g., steroid therapy, diabetes mellitus, prior vitamin D treatment) must be rigorously excluded or controlled, and the assignment of patients to the two groups must be random. These controls--sufficient study duration, sufficient patient numbers, and randomization--should eliminate extraneous sources of variation, including seasonal periodicity. This carefully developed, double-blind clinical trial with multiple participating centers and an effective organizational structure is coming close to achieving the goals of the study. An explosion of data regarding the natural history of chronic renal insufficiency and its treatment with vitamin D metabolites will be forthcoming at the conclusion of the study. 相似文献
65.
66.
67.
68.
69.
70.
B H Ault F B Stapleton M L Rivas F B Waldo S Roy R H McLean J A Bin R J Wyatt 《The Journal of pediatrics》1990,117(5):753-755